![The Asian Pacific Association for the Study of the Liver [APASL]](http://apasl.info/app-def/S-102/apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png){kind=logo}
Updated Topics
Information on APASL 2020 in Bali
Here's a video of APASL 2020 in Bali. Check it out!
Date: March 4-8, 2020
City: Bali, Indonesia
President: Dr. Rino Gani
View APASL 2020 Website
View APASL 2020 Announcement Sep-Oct (PDF)
"Liver Diseases in the Asia Pacific Region"
Dear APASL Members,
Please check "Liver Diseases in the Asia Pacific Region" published in The Lancet Gastroenterology and Hepatology on December 15. You will find it useful. Click on the image and access to the paper. If you like it, please share with your colleagues.
Hep-I OFFICIAL Twitter page has opened!
Hepatology International official Twitter page has opened!
You can check it out from the link below. Please follow us!
https://twitter.com/hepinternation1?s=20
You can also check out Hepatology International from here!
APASL STC 2020 Yangon
Pamphlet of APASL STC 2020 is now available!
This STC will be the 36th Single Topic Conference of APASL and the 8th APASL HCV Conference.
The topic is "Elimination of HCV"
Click on the image and check the PDF to see the information of this meeting!
- DATE AND LOCATION:
- DATE: December 5-6, 2020
- LOCATION: Novotel Yangon Max Hotel, Yangon, Myammar
- CONTACTS:
- OFFICIAL WEBSITE: https://www.apaslstc2020yangon.com
- E-MAIL: secretariat@apaslstc2020yangon.com
Call to Action for HCV Elimination Signed.
On November 10 at AASLD meeting, "Call to Action for Liver Association to Advance Progress Towards Viral Hepatitis Elimination: A Focus on Simplified Approaches to HCV Testing and Cure" was signed between AASLD, EASL, APASL, ALEH and acknowledgement of collaboration with CHAI, Clinton Health Access Initiative. As the number of patients of HCV is increasing all over the world, we have decided to work together to eliminate the patients until 2030. We are focusing on 4 specific themes that address the roles that liver associations and their constituents should play in eliminating HCV:
[Simplification] of diagnostic and treatment algorithms towards the goal of a one-stop "test and cure" for HCV
[Integration] of HCV treatment with primary care and other disease programs (e.g. TB, HIV) and outreach settings(harm reduction)
[Decentralization] of HCV services from large urban referral hospitals to local level care
[Task-sharing] of HCV care for Uncomplicated cases with primary care clinicians, medical officers, advanced practice clinicians, nurses, pharmacists and trained community health workers where available.
We continue working hard on eliminating HCV patients.
APASL Official YouTube Channel has been launched!
The APASL official YouTube Channel has been launched! You can watch the highlights of APASL scientific programs. Click on the image below and check it out!
APASL 2020 Bali Second Announcement [IMPORTANT NOTICE]
Dear APASL Members,
We would like to announce the 2nd Announcement which has the following update:
1. All Price already convert to USD (This announcement specially made for international participants)
2. We put General Information such us Climate, Airport Tax, Currency, Passport and Visa requirements, etc.
3. Update Scientific Program at a glance
4. Each hotel has a direct official website link.
Log on to the website http://apasl2020.org/ (click Registration Menu)
- Follow official Instagram & Facebook of APASL 2020:
- Instagram: https://www.instagram.com/apasl2020_official/?igshid=1iyzwrrbuympw
- Facebook: https://www.facebook.com/APASL2020/
More Information : +62 821 2043 1114/ +62 812 1000 6021
Hep-I Impact Factor jumped up to 5.49!
Dear Colleagues,
Hepatology International, in association with Springer Nature, is extremely delighted to share with you the 2018 Impact Factor of HEPI which has touched a new high of 5.49 from 4.11 in 2017. More so, we have jumped into the TOP 20 Journals of Gastroenterology and Hepatology and are placed at position 17.
A significant feat for our journal indeed!
It never goes without saying that this would not have been possible without your support.
We look forward to grow together as a team and steer our journal, Hepatology International, towards a more purposeful space in the field of hepatology.
With best regards,
Prof Masao Omata / Prof. Shiv Sarin
SharedIt services: A boon for Authors/Researchers
SharedIt is part of Springer Nature initiative that allows authors to share their research to wider communities by enabling over 200 key media outlets and blogs to link to free-to-read versions of research articles. This media list has been significantly expanded to coincide with the expansion of the initiative across the Springer Nature portfolio. Many on this media list are aimed at the public, including BBC, The Economist, WIRED, The New York Times, as well as leading science bloggers.
Upon publication, corresponding authors are emailed a shareable link to view-only versions of their peer-reviewed research papers. All corresponding authors are sent this link, even those with papers published in open access journals. A stable, shortened URL is made available for published authors to share the full-text access to their paper by using the link http://rdcu.be/p2UW
Enhanced PDF: The link takes the author to a read-only enhanced PDF format of their published paper.
For open-access articles, all readers will be able to download, print and save an enhanced PDF, or to view the full-text HTML version.
For subscription articles, only subscribers will be able to download, print and save an enhanced PDF, or to view the full-text HTML version.
Authors can request shareable links of other research articles that they have authored with most Springer Nature journals by entering the article's DOI into our author portal
Springer Nature has a sample social media plan to help authors promote their research via Facebook and Twitter. The four-week campaign utilizes the SharedItlink to gain visibility through concentrated daily marketing, using both direct and indirect (post comments) methods.
For more Information please visit the SharedIt page on Springernature.com.
APASL STC
APASL STC 2020 on Portal Hypertension in China
| Date: June 5-7, 2020 City: Guangzhou, China President: Dr. Xiaolong Qi Website: www.apaslstc.com |
|
APASL STC 2020 on Alcohol Liver in India
| Date: August 29-30, 2020 City: Gangtok, India President: Dr. M.R Kotwal Website: to be announced. |
APASL STC 2020 on Molecular Biology in Japan
| Date: September 24-26, 2020 City: Osaka, Japan President: Dr. Norifumi Kawada Website: http://www.apaslstc-osaka2020.org/ |
|
APASL STC 2020 on Elimination of Hepatitis C in Myanmar
| Date: December 5-6, 2020 City: Yangon, Myanmar President: Dr. Khin Maung Win Website: http://www.apaslstc2020yangon.com/ Hosting Organization: GI and Liver Foundation (GLF) (Myanmar) Conference President: Prof. Khin Maung Win Organizing Chairperson: Prof. Than Than Swe Organizing Vice-Chairs: Prof. Kyaw Soe Tun and Prof. Win Naing Academic Committee Chairperson: Prof. Khin Maung Win Conference Secretariat: Yangon GI and Liver Centre (YGLC) yangongiandlivercentre@gmail.com secretariat@apaslstc2020yangon.com |
|
APASL Oncology 2020
| Date: December 17-19, 2020 City: Tokyo, Japan President: Dr. Mitsuhiko Moriyama Website: http://www.apasl-oncology2020.org/ |
|
APASL 2021 Annual Meeting in Thailand
| Date: February 3-6, 2021 City: Bangkok, Thailand President: Dr. Tawesak Tanwandee Website: www.apasl2021bangkok.org |
|
APASL STC 2021 on Critical Care in Hepatology: ACLF
| Date: September 17-19, 2021 City: Wuhan, China President: Dr. Qin Ning Website: www.apaslstc2021wh.com |  |
APASL STC 2021 on NAFLD/NASH: Non-Infection Epidemic in XXI
| Date: September 24-26, 2020 City: Yerevan, Armenia President: Dr. Hasmik Ghazinian Website: to be announced. |
|
APASL STC 2021 on Advances in the Prevention and Management of Liver Cirrhosis and Its Complication
| Date: June 11-12, 2021 City: Manila, Philippines President: Dr. Ian Homer Y. Cua Website: to be announced. |
APASL 2022 Annual Meeting in Korea
| Date: March 30-April 3, 2022 City: COEX, Seoul, Korea President: Dr. Jin Mo Yang Website: to be announced. |
|
Related Meetings
Global Hepatitis Summit 2020
| Date: June 18-21, 2020 City: Taipei, Taiwan Website: https://ghs2020taipei.com/ |
|
APDW 2020
| Date: September 17-20, 2020 City: Kuala Lumpur, Malaysia Website: https://www.apdw2020.org/ |
|
Hep-I Impact Factor jumped up to 5.49!
Dear Colleagues,
Please be informed the Impact Factor of our Official Journal “Hepatology International” is now 5.49!
Masao Omata MD
Shiv K Sarin MD
Chief in Editor of Hepatology International
APASL Guidelines
The Guideline written by Dr. T Kanda has been published!
APASL Guidelines for HCC -”Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update” (Hepatol Int 2017; 11: 317-370)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for HBV -"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update" (Hepatol Int 2016; 10:1–98)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for HCV -”APASL consensus statements and recommendation for hepatitis C prevention, epidemiology, and laboratory testing” (Hepatol Int 2016 10:681–701)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for HCV -”APASL consensus statements and recommendation on treatment of hepatitis C” (Hepatol Int 2016 10:702–726)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for Acute-on-chronic Liver Failure -”Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014” (Hepatol Int 2014; 8: 453-471)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for Fibrosis -”Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)” (Hepatol Int 2009; 3: 323-333)
*This APASL Guideline can be downloaded by clicking below.
APASL consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis a 2016 update (Hepatol Int 2017 11:1–30)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for IPH -”Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment” (Hepatol Int 2007; 1: 398-413)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for Variceal Bleeding -”Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver” (Hepatol Int 2008; 2: 429-439)
*This APASL Guideline can be downloaded by clicking below.
APASL Fellowship 2020
The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2020 fellowship.
An application form can be downloaded by clicking here: http://apasl.info/applicationform-fellowship.docx Please fill in and send to the APASL secretariat (apasl_secretariat@apasl.info). We are looking forward to receiving your application. There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL. Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.